A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.
about
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneImmunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysisInterferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosisImmunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisHow type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.G protein-coupled receptors as therapeutic targets for multiple sclerosis.Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?Autonomic dysfunction, immune regulation, and multiple sclerosis.Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
P2860
Q21558407-F4BFB379-028A-4F9D-8D54-A13B8C11AAFAQ24187126-99D019FE-EE40-4F06-95CC-E29921CE04CFQ24194800-B3952ADB-BC50-4D33-BB97-CA75EFD935E5Q24202108-42DD15B1-2E1F-4394-BF87-D63419D2335CQ33988240-03431B07-2052-4ECD-804F-3960DA14374EQ36202727-14A5D551-2D72-4683-BE65-4D01F039C81AQ36613389-D5CE14BD-DEB6-4C39-905F-64111C1D695FQ37112554-59CBF5E0-60D0-490D-8ECE-C62F9B3531DCQ37997089-90C58DE8-D2EF-483F-AD29-BB76E1C0ED1CQ38052870-DBED3667-656D-4236-889B-F9AFD092C453Q38675737-349E4282-85FD-4E31-ABF5-64FE7A7CE728Q38689611-0ACEFBBF-7B77-43D5-96B5-FCDF733B8D78Q48313508-9E82F056-F8CA-42BA-ACCC-39B24ACB0F52
P2860
A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A randomized controlled double ...... ients with multiple sclerosis.
@ast
A randomized controlled double ...... ients with multiple sclerosis.
@en
A randomized controlled double ...... ients with multiple sclerosis.
@nl
type
label
A randomized controlled double ...... ients with multiple sclerosis.
@ast
A randomized controlled double ...... ients with multiple sclerosis.
@en
A randomized controlled double ...... ients with multiple sclerosis.
@nl
prefLabel
A randomized controlled double ...... ients with multiple sclerosis.
@ast
A randomized controlled double ...... ients with multiple sclerosis.
@en
A randomized controlled double ...... ients with multiple sclerosis.
@nl
P2093
P2860
P50
P1433
P1476
A randomized controlled double ...... tients with multiple sclerosis
@en
P2093
Brian C Healy
David A Hafler
Guy Buckle
Josiah F Wedgwood
Pia Kivisäkk
Sandra Cook
Susheel Reddy
Vissia Viglietta
P2860
P304
P356
10.1001/ARCHNEUROL.2010.222
P577
2010-09-01T00:00:00Z